Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
about
Autophagy, cell death, and cancerSustained proliferation in cancer: Mechanisms and novel therapeutic targetsRectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility.eRapa restores a normal life span in a FAP mouse model.Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells.Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc(Δ716) mice involves stromal COX-2.Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity.ENaCs and ASICs as therapeutic targets.Multimodal imaging of growth and rapamycin-induced regression of colonic adenomas in apc mutation-dependent mouse.Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceOncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.Characterization of hERG1 channel role in mouse colorectal carcinogenesis.The role of autophagy in cancer: therapeutic implications.Role of anoctamins in cancer and apoptosis.Ion channels in regulated cell death.The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling.Wnt Signaling in Normal and Malignant Stem Cells.Dysregulation of epithelial Na+ absorption induced by inhibition of the kinases TORC1 and TORC2.Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells).The large conductance Ca(2+) -activated K(+) (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases.Hypothesis: cell signalling influences age-related risk of colorectal cancer.Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: pharmacological perspectives.Mechanistic study of the anti-cancer effect of Gynostemma pentaphyllum saponins in the Apc(Min/+) mouse model.Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport
P2860
Q26745692-0BDBC1C5-FB79-4F0E-A122-D1441CCD6045Q28396388-E9835ABA-C912-4A64-87B9-B58872094038Q30540580-41F3BCEA-6EB5-40B3-961E-E8E4A7300218Q33760600-AE67879E-9894-498E-89DC-F26A581729F0Q34288979-43411858-8E1B-4196-8327-A25A8F99B329Q35019696-174D6F0B-39FB-4999-8825-61BD2CDED69FQ35157058-7FEFB442-A7BF-4761-992D-1CFF5CBA5A0CQ35754265-A4A5B8F0-9EBD-4389-A145-1FA8509150E9Q35763147-B8D403E6-5E6A-4A58-BAB6-ED770A67EB34Q35900722-58FB7867-34BD-42CD-A546-C8A14656A512Q36310643-DCF20A49-A868-41EE-9FFE-A4A94D27034BQ36656385-5D61599C-E92B-4CF2-955E-91CB34B47056Q36786996-6F7B0167-1C4A-49C3-9D38-9BD13D425F1EQ37438495-06187A1A-75BF-43B9-94D0-B39E2B1341E7Q37482529-5D0676D1-153A-47C9-B074-F47412F53AB3Q37924056-8C527AE8-C1CF-48A3-9BAB-D4E572B75049Q38184980-DC576E9C-0ED2-4540-A239-3FC3A6D02682Q38811371-0CE65F51-AE6D-43CB-A770-2CE48F5C1D38Q39297991-72088168-D3B8-459D-8BD9-4238D70004F6Q39306017-C8C6E157-1F76-48E5-ADF5-000B6E543B62Q41485386-314543C2-79DF-4284-90C6-8F7D543C6095Q41865893-D8FC0E16-4FBD-4E10-AD06-B8E697F0EBFEQ42275382-B996710A-5590-4AFB-BA32-6FA648938E8FQ42468347-288526C4-6BA7-44A8-A94A-7A1FA86A4B95Q46202283-4E4E006D-5EAB-421E-8DA1-3598FEE8B328Q53149885-2C21193E-F1D5-4518-A55D-3BD023F3A078Q58484730-AE6692C9-7930-413E-A762-AD95E7D8CF6A
P2860
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC
@nl
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
@en
type
label
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC
@nl
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
@en
prefLabel
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC
@nl
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
@en
P2093
P2860
P356
P1433
P1476
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
@en
P2093
E K Geissler
J Ousingsawat
M Spitzner
R Schreiber
P2860
P2888
P304
P356
10.1038/ONC.2009.435
P407
P577
2009-12-07T00:00:00Z
P6179
1045005573